B3GAT2 Gene - Beta-1,3-Glucuronyltransferase 2

Key enzyme in glycosaminoglycan biosynthesis and neural development

Gene Information Card

Symbol B3GAT2
Full Name Beta-1,3-Glucuronyltransferase 2
Gene Type Protein coding
Chromosomal Location 6q13
NCBI Gene ID 27087 ncbi.nlm.nih.gov/gene/27087
Ensembl ID ENSG00000112297
UniProt ID Q9NPZ5
OMIM ID 606978
HGNC ID 953
Aliases GlcAT-S, GlcAT-2, GlcUAT-2, B3GAT2

Description

B3GAT2 (Beta-1,3-Glucuronyltransferase 2) encodes a member of the glucuronyltransferase family. This enzyme catalyzes the transfer of glucuronic acid from UDP-glucuronic acid to the terminal galactose of the glycosaminoglycan-protein linkage region, a critical step in the biosynthesis of heparan sulfate and chondroitin sulfate. B3GAT2 is predominantly expressed in the brain and is involved in neural development and synaptic plasticity.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Schizophrenia Altered expression may affect neurodevelopment and synaptic function; genetic association studies suggest linkage PMID: 19012866
Bipolar disorder Potential involvement in glycosaminoglycan metabolism affecting neuronal signaling PMID: 19012866
Intellectual disability Rare variants in B3GAT2 have been identified in patients with developmental delay ClinVar SCV000803123

Expression Profile

Tissue Expression
Tissue nTPM level
Brain (cerebellum) 12.5 Medium
Brain (cortex) 10.2 Medium
Testis 3.1 Low
Heart 1.8 Low
Liver 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 8.4 Neuronal model
U-87 MG (glioblastoma) 6.7 Glial model
HEK293 (embryonic kidney) 2.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1015C>T (p.Arg339Trp) Missense <0.01% Likely pathogenic; associated with intellectual disability
c.124G>A (p.Gly42Ser) Missense <0.01% Uncertain significance
c.1489_1490del (p.Leu497fs) Frameshift <0.01% Loss of function; reported in ClinVar
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations are predicted to cause loss of enzyme activity, impairing glycosaminoglycan synthesis.

Gain of Function (GOF)

No gain-of-function mutations have been reported.

Dominant Negative (DN)

No dominant-negative mechanisms have been described.

Pathways

Glycosaminoglycan biosynthesis – heparan sulfate / heparin (KEGG: hsa00534)
Glycosaminoglycan biosynthesis – chondroitin sulfate / dermatan sulfate (KEGG: hsa00532)

Protein Summary

The B3GAT2 protein (UniProt Q9NPZ5) is a type II transmembrane glycoprotein localized to the Golgi apparatus. It contains a short N-terminal cytoplasmic tail, a transmembrane domain, and a large C-terminal catalytic domain. The enzyme transfers glucuronic acid to the tetrasaccharide linkage region of proteoglycans, essential for elongation of heparan sulfate and chondroitin sulfate chains. Its expression is highest in neural tissues, suggesting a specialized role in brain development and function.

Related Products

Product name Cat.No. Species Gene ID
B3GAT2 Knockout HEK293 Cell Line EDJ-KQ9356 Human 135152 Details Get a Quote
B3GAT2 Knockout HeLa Cell Line EDJ-KQ58348 Human 135152 Details Get a Quote
B3GAT2 Knockout A-549 Cell Line EDJ-KQ66837 Human 135152 Details Get a Quote
B3GAT2 Knockout HCT 116 Cell Line EDJ-KQ75240 Human 135152 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: